Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
- PMID: 31435171
- PMCID: PMC6700703
- DOI: 10.3748/wjg.v25.i30.4172
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
Abstract
Lysosomal acid lipase (LAL) plays a key role in intracellular lipid metabolism. Reduced LAL activity promotes increased multi-organ lysosomal cholesterol ester storage, as observed in two recessive autosomal genetic diseases, Wolman disease and Cholesterol ester storage disease. Severe liver steatosis and accelerated liver fibrosis are common features in patients with genetic LAL deficiency. By contrast, few reliable data are available on the modulation of LAL activity in vivo and on the epigenetic and metabolic factors capable of regulating its activity in subjects without homozygous mutations of the Lipase A gene. In the last few years, a less severe and non-genetic reduction of LAL activity was reported in children and adults with non-alcoholic fatty liver disease (NAFLD), suggesting a possible role of LAL reduction in the pathogenesis and progression of the disease. Patients with NAFLD show a significant, progressive reduction of LAL activity from simple steatosis to non-alcoholic steatohepatitis and cryptogenic cirrhosis. Among cirrhosis of different etiologies, those with cryptogenic cirrhosis show the most significant reductions of LAL activity. These findings suggest that the modulation of LAL activity may become a possible new therapeutic target for patients with more advanced forms of NAFLD. Moreover, the measurement of LAL activity may represent a possible new marker of disease severity in this clinical setting.
Keywords: Cholesterol ester storage disease; Cirrhosis; Lysosomal acid lipase; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Wolman disease.
Conflict of interest statement
Conflict-of-interest statement: No potential conflicts of interest. No financial support.
Figures
Similar articles
-
Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase.J Lipid Res. 2023 Sep;64(9):100427. doi: 10.1016/j.jlr.2023.100427. Epub 2023 Aug 16. J Lipid Res. 2023. PMID: 37595802 Free PMC article.
-
Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.J Clin Pathol. 2018 Jul;71(7):608-613. doi: 10.1136/jclinpath-2017-204727. Epub 2018 Jan 22. J Clin Pathol. 2018. PMID: 29358478
-
Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?Int J Mol Sci. 2015 Nov 25;16(12):28014-21. doi: 10.3390/ijms161226085. Int J Mol Sci. 2015. PMID: 26602919 Free PMC article. Review.
-
Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(1):99-106. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014. PMID: 24798600 Review.
-
Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.J Hepatol. 2013 Sep;59(3):543-9. doi: 10.1016/j.jhep.2013.04.016. Epub 2013 Apr 25. J Hepatol. 2013. PMID: 23624251 Free PMC article.
Cited by
-
Association of Altered Plasma Lipidome with Disease Severity in COVID-19 Patients.Biomolecules. 2024 Mar 1;14(3):296. doi: 10.3390/biom14030296. Biomolecules. 2024. PMID: 38540716 Free PMC article.
-
Evaluation of Hepatitis in Pediatric Patients With Presumed Nonalcoholic Fatty Liver Disease.JPGN Rep. 2022 Mar 9;3(2):e181. doi: 10.1097/PG9.0000000000000181. eCollection 2022 May. JPGN Rep. 2022. PMID: 37168906 Free PMC article.
-
Lysosomal acid lipase deficiency: A rare inherited dyslipidemia but potential ubiquitous factor in the development of atherosclerosis and fatty liver disease.Front Genet. 2022 Sep 20;13:1013266. doi: 10.3389/fgene.2022.1013266. eCollection 2022. Front Genet. 2022. PMID: 36204319 Free PMC article. Review.
-
Ameliorative effects of high intensity interval training and Lactobacillus rhamnosus GG Protect against tetracycline-induced fatty liver in rats: a gene expression profiling comparative study.EXCLI J. 2022 Jul 21;21:991-1006. doi: 10.17179/excli2022-4791. eCollection 2022. EXCLI J. 2022. PMID: 36110559 Free PMC article.
-
Molecular markers of brain cholesterol homeostasis are unchanged despite a smaller brain mass in a mouse model of cholesteryl ester storage disease.Lipids. 2022 Jan;57(1):3-16. doi: 10.1002/lipd.12325. Epub 2021 Oct 7. Lipids. 2022. PMID: 34618372 Free PMC article.
References
-
- Fasano T, Pisciotta L, Bocchi L, Guardamagna O, Assandro P, Rabacchi C, Zanoni P, Filocamo M, Bertolini S, Calandra S. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. Mol Genet Metab. 2012;105:450–456. - PubMed
-
- Reiner Ž, Guardamagna O, Nair D, Soran H, Hovingh K, Bertolini S, Jones S, Ćorić M, Calandra S, Hamilton J, Eagleton T, Ros E. Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis. 2014;235:21–30. - PubMed
-
- Bernstein DL, Hülkova H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013;58:1230–1243. - PubMed
-
- Valayannopoulos V, Malinova V, Honzík T, Balwani M, Breen C, Deegan PB, Enns GM, Jones SA, Kane JP, Stock EO, Tripuraneni R, Eckert S, Schneider E, Hamilton G, Middleton MS, Sirlin C, Kessler B, Bourdon C, Boyadjiev SA, Sharma R, Twelves C, Whitley CB, Quinn AG. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency. J Hepatol. 2014;61:1135–1142. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical